ConductScience.org, home

Paper526397

Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.

McNeil JJ and 3 others. Br J Clin Pharmacol, 1979. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects. Papers, record 526397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526397

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.9
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McNeil JJJ J
2Anderson AEA E
3Louis WJW J
4Morgan DJD J

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EthanolaminesMajor topic
HypertensionMajor topic
LabetalolMajor topic
Administration, Oral
Adult
Aged
Blood Pressure
Female
Half-Life
Humans
Injections, Intravenous
Kinetics
Male
Middle Aged
Time Factors

Source PubMed

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,010Relationship between plasma concentrations and pharmacological effects of labetalol.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/14010PubMed
210,951Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10951PubMed
3285,681Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.Aust N Z J Med1978https://conductscience.org/library/papers/285681PubMed
45,411,325Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.J Pharm Sci1970https://conductscience.org/library/papers/5411325PubMed
5990,152Metabolism of labetalol by animals and man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/990152PubMed
64,404,413Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.Br J Pharmacol1972https://conductscience.org/library/papers/4404413PubMed
74,148,916Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A.Br J Pharmacol1972https://conductscience.org/library/papers/4148916PubMed
8709,214Decreased first-pass metabolism of labetalol in chronic liver disease.Br Med J1978https://conductscience.org/library/papers/709214PubMed

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
38,973,651Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms.J Clin Pharmacol2024https://conductscience.org/library/papers/38973651PubMed
37,142,805Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women.Pharm Res2023https://conductscience.org/library/papers/37142805PubMed
35,000,148Pseudopheochromocytoma: an Uncommon Cause of Severe Hypertension.Curr Cardiol Rep2022https://conductscience.org/library/papers/35000148PubMed
34,112,223Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.Crit Care2021https://conductscience.org/library/papers/34112223PubMed
31,875,885Measuring effects of medication adherence on time-varying health outcomes using Bayesian dynamic linear models.Biostatistics2021https://conductscience.org/library/papers/31875885PubMed
31,655,774Pseudopheochromocytoma.Endocrinol Metab Clin North Am2019https://conductscience.org/library/papers/31655774PubMed
27,738,531Pseudopheochromocytoma Associated with Domestic Assault.Case Rep Cardiol2016https://conductscience.org/library/papers/27738531PubMed
26,186,619Labetalol Prevents Intestinal Dysfunction Induced by Traumatic Brain Injury.PLoS One2015https://conductscience.org/library/papers/26186619PubMed
23,327,720Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.Mol Pharm2013https://conductscience.org/library/papers/23327720PubMed
21,272,200Drug therapy for resistant hypertension: simplifying the approach.J Clin Hypertens (Greenwich)2011https://conductscience.org/library/papers/21272200PubMed
18,367,021Severe paroxysmal hypertension (pseudopheochromocytoma).Curr Hypertens Rep2008https://conductscience.org/library/papers/18367021PubMed
17,786,066Combined alpha/beta-blockade: an underused approach to the treatment of resistant hypertension.J Clin Hypertens (Greenwich)2007https://conductscience.org/library/papers/17786066PubMed
7,295,464Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7295464PubMed
7,104,187Bioavailability of labetalol increases with age.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104187PubMed
7,104,169The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104169PubMed
7,093,102Labetalol steady-state pharmacokinetics in hypertensive patients.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093102PubMed
6,370,541Clinical pharmacokinetics of labetalol.Clin Pharmacokinet1984https://conductscience.org/library/papers/6370541PubMed
6,151,889Pharmacology of combined alpha-beta-blockade. I.Drugs1984https://conductscience.org/library/papers/6151889PubMed
2,663,413Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.Drugs1989https://conductscience.org/library/papers/2663413PubMed
1,884,570Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.Clin Pharmacokinet1991https://conductscience.org/library/papers/1884570PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/526397

GET https://conductscience.org/api/papers/v1/526397/authors